Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.
OPKO 4Kscore(R) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection more »
OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress on Its Long-Acting Clotting Factor VIIa more »
OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.